United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $830,859,703.10
- April 7, 2025
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 27, 2024 | CEO | 3,600 | $316.62 | Sell | $1,139,832.00 | |
June 25, 2024 | Director | 266 | $318.58 | Sell | $84,742.28 | |
June 24, 2024 | CEO | 3,600 | $315.97 | Sell | $1,137,492.00 | |
June 21, 2024 | CEO | 3,600 | $313.91 | Sell | $1,130,076.00 | |
June 14, 2024 | CEO | 3,600 | $287.22 | Sell | $1,033,992.00 | |
June 13, 2024 | Director | 2,000 | $281.53 | Sell | $563,060.00 | |
June 12, 2024 | CEO | 3,600 | $281.19 | Sell | $1,012,284.00 | |
June 10, 2024 | CEO | 3,600 | $273.95 | Sell | $986,220.00 | |
June 7, 2024 | CEO | 3,600 | $277.13 | Sell | $997,668.00 | |
May 31, 2024 | CEO | 3,600 | $272.48 | Sell | $980,928.00 | |
May 28, 2024 | Director | 3,600 | $269.06 | Sell | $968,616.00 | |
May 23, 2024 | Director | 3,600 | $275.78 | Sell | $992,808.00 | |
May 21, 2024 | Director | 1,468 | $275.85 | Sell | $404,947.80 | |
May 16, 2024 | Director | 3,600 | $272.37 | Sell | $980,532.00 | |
May 14, 2024 | Director | 1,310 | $264.35 | Sell | $346,298.50 | |
May 13, 2024 | CEO | 3,600 | $265.48 | Sell | $955,728.00 | |
May 9, 2024 | CEO | 3,600 | $264.22 | Sell | $951,192.00 | |
May 6, 2024 | CEO | 3,600 | $259.70 | Sell | $934,920.00 | |
May 3, 2024 | Director | 2,240 | $259.91 | Sell | $582,198.40 | |
May 2, 2024 | CEO | 3,600 | $258.09 | Sell | $929,124.00 | |
April 30, 2024 | CEO | 3,600 | $235.35 | Sell | $847,260.00 | |
April 26, 2024 | CEO | 3,600 | $235.20 | Sell | $846,720.00 | |
April 24, 2024 | CEO | 3,600 | $238.81 | Sell | $859,716.00 | |
April 22, 2024 | CEO | 3,600 | $236.47 | Sell | $851,292.00 | |
April 18, 2024 | CEO | 3,600 | $237.91 | Sell | $856,476.00 | |
April 16, 2024 | CEO | 3,600 | $232.05 | Sell | $835,380.00 | |
April 12, 2024 | CEO | 3,600 | $235.42 | Sell | $847,512.00 | |
April 10, 2024 | CEO | 13,800 | $237.27 | Sell | $3,274,326.00 | |
April 8, 2024 | CEO | 5,060 | $237.52 | Sell | $1,201,851.20 | |
April 4, 2024 | EVP | 6,000 | $232.37 | Sell | $1,394,220.00 | |
April 4, 2024 | CEO | 15,000 | $233.27 | Sell | $3,499,050.00 | |
March 28, 2024 | CEO | 14,125 | $236.18 | Sell | $3,336,042.50 | |
March 27, 2024 | Director | 325 | $237.80 | Sell | $77,285.00 | |
March 26, 2024 | CEO | 15,000 | $248.33 | Sell | $3,724,950.00 | |
March 22, 2024 | CEO | 15,000 | $237.05 | Sell | $3,555,750.00 | |
March 21, 2024 | EVP | 6,000 | $236.45 | Sell | $1,418,700.00 | |
March 19, 2024 | CEO | 15,000 | $236.59 | Sell | $3,548,850.00 | |
Feb. 23, 2024 | Director | 1,680 | $224.00 | Sell | $376,320.00 | |
Feb. 15, 2024 | EVP | 6,000 | $215.31 | Sell | $1,291,860.00 | |
Feb. 1, 2024 | EVP | 6,000 | $215.01 | Sell | $1,290,060.00 | |
Jan. 18, 2024 | EVP | 6,000 | $218.72 | Sell | $1,312,320.00 | |
Jan. 4, 2024 | EVP | 6,000 | $227.97 | Sell | $1,367,820.00 | |
Dec. 21, 2023 | EVP | 6,000 | $229.27 | Sell | $1,375,620.00 | |
Dec. 19, 2023 | Director | 605 | $244.90 | Sell | $148,164.50 | |
Dec. 12, 2023 | Director | 3,000 | $249.68 | Sell | $749,040.00 | |
Dec. 7, 2023 | EVP | 6,000 | $238.89 | Sell | $1,433,340.00 | |
Nov. 2, 2023 | EVP | 6,000 | $225.76 | Sell | $1,354,560.00 | |
Oct. 19, 2023 | EVP | 6,000 | $225.43 | Sell | $1,352,580.00 | |
Oct. 5, 2023 | EVP | 6,000 | $223.82 | Sell | $1,342,920.00 | |
Sept. 21, 2023 | EVP | 6,000 | $222.19 | Sell | $1,333,140.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Judy D. Olian, R Paul Gray, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, and DWEK RAYMOND
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on April 7, 2025.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.